In the rapidly evolving field of cell therapy research, cell lines are a stable and renewable resource for investigating disease mechanisms, testing therapeutic candidates, and pioneering new cell-based treatments. Proper and efficient management of cell line data, license agreement terms, and audit logs are critical for success. Finding the right cell line management solution, like […]
View Blog
Across the globe, access to life-saving cell and gene therapies like CAR T-cell therapy remains largely limited to wealthier nations and well-resourced health systems. While the clinical outcomes of these therapies can be extraordinary—offering cures for certain blood cancers—their high cost and complexity of production present a barrier that many countries cannot overcome. But a […]
View Blog
Mesenchymal stem cells (MSCs) have long shown promise in regenerative medicine, with the potential to treat everything from heart disease to autoimmune conditions. But for decades, MSC therapies struggled to move beyond early-phase clinical trials and regional approvals. That changed in December 2024 when the U.S. Food and Drug Administration (FDA) approved RYONCIL—and it became […]
View Blog
In the fast-paced world of clinical research, efficiency, accuracy, and compliance are critical to successful study outcomes. The right LIMS should aim to streamline clinical sample workflows, improve data accuracy, and support compliance with clinical sample management. Here’s a closer look at the features clinical researchers should focus on and how they benefit those actively […]
View Blog
Access to cutting-edge gene therapy treatments remains a major challenge, particularly in low- and middle-income countries (LMICs). While these therapies hold the potential to cure life-threatening conditions such as hemophilia, HIV, and sickle cell disease, their availability today is generally limited to patients in wealthier nations with advanced medical infrastructure. The Global Gene Therapy Initiative […]
View Blog
In laboratory environments, sample integrity is critical to ensuring reliable research results, workflow efficiency, and cost-effectiveness. While often overlooked, sample storage tubes play a pivotal role in protecting samples, streamlining processes, and supporting automation. Sample storage and handling requires a variety of tubes, each designed to meet specific needs related to the sample type, storage […]
View Blog
In early January 2025, Bridging the Gap panelists George Eastwood and Patrick Hanley visited Washington, D.C., to advocate for increased support and funding for life-saving cell and gene therapies. Insights from our January 2025 Bridging the Gap Webinar During its first year, the Bridging the Gap Webinar Series, sponsored by Azenta Life Sciences and the […]
View Blog
Scientific research is the cornerstone of innovation, but it can come at an environmental cost. In the pursuit of scientific advancement, life sciences laboratories have become significant contributors to global plastic waste, where consumables like pipette tips, gloves, and culture flasks are essential for experiments. Unfortunately, these items are primarily single-use and plastic-based, leading to […]
View Blog
Azenta Life Sciences has officially opened its state-of-the-art biorepository facility in the Greater Boston area, designed to serve the unique storage and management needs of the biotech and life sciences industries. Located strategically to support Cambridge and Boston’s vibrant community of biotech and pharmaceutical companies, the facility offers advanced sample storage and handling capabilities, helping […]
View Blog
Insights from our December 2024 Bridging the Gap Webinar Groundbreaking advancements in cell and gene therapies offer unprecedented hope for patients battling cancers, autoimmune diseases, and genetic disorders. Yet, transforming academic breakthroughs into therapies ready for patients is a complex and challenging journey. Issues such as scalable manufacturing processes, navigating diverse regulatory frameworks, and expanding […]
View Blog